StockData
MediWound Ltd. logo

MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.59+0.05 (+0.37%)

Close on Nov 20, 2026Market cap $174.43MP/E –Yield –

MediWound free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$21.63M. The highest annual figure on record is $7.50M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.63M–
FY2024Dec 31, 2024-$19.90M–
FY2023Dec 31, 2023-$16.93M–
FY2022Dec 31, 2022-$12.44M–
FY2021Dec 31, 2021-$9.41M–
FY2020Dec 31, 2020-$7.82M-204.3%
FY2019Dec 31, 2019$7.50M–
FY2018Dec 31, 2018-$12.68M–
FY2017Dec 31, 2017-$17.50M–
FY2016Dec 31, 2016-$17.12M–
FY2015Dec 31, 2015-$19.98M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.20M–
Q2 FY2025Jun 30, 2025-$6.81M–
Q2 FY2024Jun 30, 2024-$6.64M–
Q2 FY2023Jun 30, 2023-$6.32M-137.0%
Q2 FY2022Jun 30, 2022-$5.39M–
Q2 FY2021Jun 30, 2021-$1.01M–
Q2 FY2020Jun 30, 2020-$2.92M–
Q2 FY2019Jun 30, 2019$17.07M–
Q2 FY2018Jun 30, 2018-$5.88M–
Q2 FY2017Jun 30, 2017-$4.41M–

More MediWound figures

See a number that looks wrong?